USPTO serial 75979773
PHARMAPRINT
Reviewed by CopyMark Law Group
Reg. 2447147Status 710
- Filing date
- Status date
- Registration date
- Apr 24, 2001
- Examiner
- CHARLON, BARNEY
- Law office
- SCANNING ON DEMAND
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with PHARMAPRINT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Irvine, CA
Irvine, CA
Irvine, CA
ABT Global Pharmaceutical Corp.
Irvine, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
EUGENE K HYUN
EUGENE K HYUN LYON & LYON LLP633 W 5TH ST STE 4700LOS ANGELES, CA 90071-2066UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals and pharmaceutical preparations based on natural medicines that-- reduce certain fatty substances in the blood, including triglycerides and cholesterol; are used in the treatment of inadequate blood flow in vessels in the extremities, including cramping pain in the calf caused by walking, and in the brain; are used in the treatment of ringing of the ears; increase sexual appetite; reduce cholesterol levels in the blood and increase the length of one's life; improve heart function; improve urination, are used in the treatment of non-cancerous enlargement of the male prostate gland, and help rid the body of worms; improve disorders of the male prostate gland, including non-cancerous enlargement; reduce the symptoms caused by non-cancerous enlargement of the male prostate gland; stimulate the body's immune system; reduce stress from environmental factors; improve mild to moderate mood depression; help in AIDS; increase resistance to infections caused by bacteria and viruses; stimulate the body's immune system; and treat immune deficiencies | SECTION 8 - CANCELLED | — |
| 040 | pharmaceutical manufacturing to the order and specifications of others | SECTION 8 - CANCELLED | — |
| 042 | pharmaceutical research; identifying and quantifying the active and effective components of natural medicines so that pharmaceutical versions can be made and tested | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PHARMAPRINT INC.
- Other trademarks owned by PHARMAPRINT INC.
- Other trademarks owned by PHARMAPRINT INC.
- Other trademarks owned by ABT Global Pharmaceutical Corp.
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Similar marks named PHARMAPRINT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 26, 2008 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Dec 5, 2006 | CFIT | CASE FILE IN TICRS | — |
| Aug 10, 2006 | CORV | REVIEW OF CORRESPONDENCE COMPLETE | — |
| Aug 2, 2002 | PAPER RECEIVED | — | |
| Apr 24, 2001 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 27, 2000 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Aug 31, 2000 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 29, 2000 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Aug 26, 2000 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Apr 19, 2000 | IUAF | USE AMENDMENT FILED | — |
| Dec 6, 1999 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 19, 1999 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jun 3, 1999 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 19, 1999 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 20, 1998 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 28, 1998 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 26, 1998 | NPUB | NOTICE OF PUBLICATION | — |
| May 12, 1998 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 19, 1997 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 11, 1997 | DOCK | ASSIGNED TO EXAMINER | — |